Membrane Assays to Characterize Interaction of Drugs with ABCB1

ATP-binding cassette sub-family B member 1 (ABCB1) [P-glycoprotein (P-gp), multidrug resistance protein 1 (MDR1)] can affect the pharmacokinetics, safety, and efficacy of drugs making it important to identify compounds that interact with ABCB1. The ATPase assay and vesicular transport (VT) assay are...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of membrane biology Vol. 248; no. 6; pp. 967 - 977
Main Authors Fekete, Zsolt, Rajnai, Zsuzsanna, Nagy, Tünde, Jakab, Katalin Tauberné, Kurunczi, Anita, Gémes, Katalin, Herédi-Szabó, Krisztina, Fülöp, Ferenc, Tóth, Gábor K., Czerwinski, Maciej, Loewen, Greg, Krajcsi, Peter
Format Journal Article
LanguageEnglish
Published New York Springer US 01.12.2015
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ATP-binding cassette sub-family B member 1 (ABCB1) [P-glycoprotein (P-gp), multidrug resistance protein 1 (MDR1)] can affect the pharmacokinetics, safety, and efficacy of drugs making it important to identify compounds that interact with ABCB1. The ATPase assay and vesicular transport (VT) assay are membrane based assays that can be used to measure the interaction of compounds with ABCB1 at a lower cost and higher throughput compared to cellular-based assays and therefore can be used earlier in the drug development process. To that end, we tested compounds previously identified as ABCB1 substrates and inhibitors for interaction with ABCB1 using the ATPase and VT assays. All compounds tested interacted with ABCB1 in both the ATPase and VT assays. All compounds previously identified as ABCB1 substrates activated ABCB1-mediated ATPase activity in the ATPase assay. All compounds previously identified as ABCB1 inhibitors inhibited the ABCB1-mediated transport in the VT assay. Interestingly, six of the ten compounds previously identified as ABCB1 inhibitors activated the basal ATPase activity in activation assays suggesting that the compounds are substrates of ABCB1 but can inhibit ABCB1 in inhibition assays. Importantly, for ATPase activators the EC 50 of activation correlated with the IC 50 values from the VT assay showing that interactions of compounds with ABCB1 can be measured with similar levels of potency in either assay. For ATPase nonactivators the IC 50 values from the ATPase inhibition and VT inhibition assay showed correlation. These results demonstrate the utility of membrane assays as tools to detect and rank order drug–transporter interactions.
AbstractList ATP-binding cassette sub-family B member 1 (ABCB1) [P-glycoprotein (P-gp), multidrug resistance protein 1 (MDR1)] can affect the pharmacokinetics, safety, and efficacy of drugs making it important to identify compounds that interact with ABCB1. The ATPase assay and vesicular transport (VT) assay are membrane based assays that can be used to measure the interaction of compounds with ABCB1 at a lower cost and higher throughput compared to cellular-based assays and therefore can be used earlier in the drug development process. To that end, we tested compounds previously identified as ABCB1 substrates and inhibitors for interaction with ABCB1 using the ATPase and VT assays. All compounds tested interacted with ABCB1 in both the ATPase and VT assays. All compounds previously identified as ABCB1 substrates activated ABCB1-mediated ATPase activity in the ATPase assay. All compounds previously identified as ABCB1 inhibitors inhibited the ABCB1-mediated transport in the VT assay. Interestingly, six of the ten compounds previously identified as ABCB1 inhibitors activated the basal ATPase activity in activation assays suggesting that the compounds are substrates of ABCB1 but can inhibit ABCB1 in inhibition assays. Importantly, for ATPase activators the EC^sub 50^ of activation correlated with the IC^sub 50^ values from the VT assay showing that interactions of compounds with ABCB1 can be measured with similar levels of potency in either assay. For ATPase nonactivators the IC^sub 50^ values from the ATPase inhibition and VT inhibition assay showed correlation. These results demonstrate the utility of membrane assays as tools to detect and rank order drug-transporter interactions.
ATP-binding cassette sub-family B member 1 (ABCB1) [P-glycoprotein (P-gp), multidrug resistance protein 1 (MDR1)] can affect the pharmacokinetics, safety, and efficacy of drugs making it important to identify compounds that interact with ABCB1. The ATPase assay and vesicular transport (VT) assay are membrane based assays that can be used to measure the interaction of compounds with ABCB1 at a lower cost and higher throughput compared to cellular-based assays and therefore can be used earlier in the drug development process. To that end, we tested compounds previously identified as ABCB1 substrates and inhibitors for interaction with ABCB1 using the ATPase and VT assays. All compounds tested interacted with ABCB1 in both the ATPase and VT assays. All compounds previously identified as ABCB1 substrates activated ABCB1-mediated ATPase activity in the ATPase assay. All compounds previously identified as ABCB1 inhibitors inhibited the ABCB1-mediated transport in the VT assay. Interestingly, six of the ten compounds previously identified as ABCB1 inhibitors activated the basal ATPase activity in activation assays suggesting that the compounds are substrates of ABCB1 but can inhibit ABCB1 in inhibition assays. Importantly, for ATPase activators the EC 50 of activation correlated with the IC 50 values from the VT assay showing that interactions of compounds with ABCB1 can be measured with similar levels of potency in either assay. For ATPase nonactivators the IC 50 values from the ATPase inhibition and VT inhibition assay showed correlation. These results demonstrate the utility of membrane assays as tools to detect and rank order drug–transporter interactions.
ATP-binding cassette sub-family B member 1 (ABCB1) [P-glycoprotein (P-gp), multidrug resistance protein 1 (MDR1)] can affect the pharmacokinetics, safety, and efficacy of drugs making it important to identify compounds that interact with ABCB1. The ATPase assay and vesicular transport (VT) assay are membrane based assays that can be used to measure the interaction of compounds with ABCB1 at a lower cost and higher throughput compared to cellular-based assays and therefore can be used earlier in the drug development process. To that end, we tested compounds previously identified as ABCB1 substrates and inhibitors for interaction with ABCB1 using the ATPase and VT assays. All compounds tested interacted with ABCB1 in both the ATPase and VT assays. All compounds previously identified as ABCB1 substrates activated ABCB1-mediated ATPase activity in the ATPase assay. All compounds previously identified as ABCB1 inhibitors inhibited the ABCB1-mediated transport in the VT assay. Interestingly, six of the ten compounds previously identified as ABCB1 inhibitors activated the basal ATPase activity in activation assays suggesting that the compounds are substrates of ABCB1 but can inhibit ABCB1 in inhibition assays. Importantly, for ATPase activators the EC50 of activation correlated with the IC50 values from the VT assay showing that interactions of compounds with ABCB1 can be measured with similar levels of potency in either assay. For ATPase nonactivators the IC50 values from the ATPase inhibition and VT inhibition assay showed correlation. These results demonstrate the utility of membrane assays as tools to detect and rank order drug-transporter interactions.
Author Loewen, Greg
Rajnai, Zsuzsanna
Kurunczi, Anita
Gémes, Katalin
Herédi-Szabó, Krisztina
Nagy, Tünde
Krajcsi, Peter
Jakab, Katalin Tauberné
Czerwinski, Maciej
Fekete, Zsolt
Tóth, Gábor K.
Fülöp, Ferenc
Author_xml – sequence: 1
  givenname: Zsolt
  surname: Fekete
  fullname: Fekete, Zsolt
  organization: Solvo Biotechnology
– sequence: 2
  givenname: Zsuzsanna
  surname: Rajnai
  fullname: Rajnai, Zsuzsanna
  organization: Solvo Biotechnology
– sequence: 3
  givenname: Tünde
  surname: Nagy
  fullname: Nagy, Tünde
  organization: Solvo Biotechnology
– sequence: 4
  givenname: Katalin Tauberné
  surname: Jakab
  fullname: Jakab, Katalin Tauberné
  organization: Solvo Biotechnology
– sequence: 5
  givenname: Anita
  surname: Kurunczi
  fullname: Kurunczi, Anita
  organization: Solvo Biotechnology
– sequence: 6
  givenname: Katalin
  surname: Gémes
  fullname: Gémes, Katalin
  organization: Solvo Biotechnology
– sequence: 7
  givenname: Krisztina
  surname: Herédi-Szabó
  fullname: Herédi-Szabó, Krisztina
  organization: Solvo Biotechnology
– sequence: 8
  givenname: Ferenc
  surname: Fülöp
  fullname: Fülöp, Ferenc
  organization: Institute of Pharmaceutical Chemistry, University of Szeged
– sequence: 9
  givenname: Gábor K.
  surname: Tóth
  fullname: Tóth, Gábor K.
  organization: Department of Medical Chemistry, Faculty of General Medicine, University of Szeged
– sequence: 10
  givenname: Maciej
  surname: Czerwinski
  fullname: Czerwinski, Maciej
  organization: XenoTech L.L.C
– sequence: 11
  givenname: Greg
  surname: Loewen
  fullname: Loewen, Greg
  organization: XenoTech L.L.C
– sequence: 12
  givenname: Peter
  surname: Krajcsi
  fullname: Krajcsi, Peter
  email: krajcsi@solvo.com
  organization: Solvo Biotechnology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25926125$$D View this record in MEDLINE/PubMed
BookMark eNp1kMtOwzAQRS1URB_wAWxQJDZsAuOJ7TQr1IZXpSI2sLbsxGlTNUmxE6Hy9bhqQQiJlR9z5s7oDEmvbmpDyDmFawoQ3zgAjDAEysNkDCzcHpEBZf6HMmQ9MvBlDFFEtE-Gzq0AaBwLdkL6yBMUFPmA3D6bSltVm2DinNq6oG2CdKmsylpjy08TzGp_8a-yqYOmCO5st3DBR9kug8k0ndJTclyotTNnh3NE3h7uX9OncP7yOEsn8zBjDNuQFzkwVBpBZ1wzXoxNQhmjieZaawGFFtEYYSyUyotYCBAip5EGoUUi4iSJRuRqn7uxzXtnXCur0mVmvfarN52TNEYOyGOMPXr5B101na39djsq4iwCZJ6ieyqzjXPWFHJjy0rZraQgd3bl3q70duXOrtz6notDcqcrk_90fOv0AO4B50v1wthfo_9N_QKtjoQc
CitedBy_id crossref_primary_10_1038_s41598_018_32770_y
crossref_primary_10_1016_j_phrs_2022_106233
crossref_primary_10_1016_j_taap_2016_03_008
crossref_primary_10_1016_j_ecoenv_2016_10_022
crossref_primary_10_1002_1873_3468_14005
crossref_primary_10_1124_dmd_121_000807
crossref_primary_10_1111_jvp_13106
crossref_primary_10_1016_j_bbrc_2021_07_031
crossref_primary_10_1038_s41551_023_01128_9
Cites_doi 10.1021/jm021012t
10.1124/jpet.105.099648
10.1023/B:PHAM.0000036913.90332.b1
10.1016/j.ejps.2013.04.032
10.1016/S0149-2918(01)80049-7
10.1006/abbi.1997.0537
10.1007/s11095-008-9678-0
10.1054/bjoc.2001.2118
10.1016/0006-2952(88)90365-6
10.1023/B:PHAM.0000026434.82855.69
10.1016/j.nucmedbio.2013.05.012
10.5414/CPP38161
10.1021/bi301532c
10.1124/dmd.112.050500
10.2967/jnumed.112.118232
10.1016/0005-2736(92)90078-Z
10.1124/dmd.32.8.800
10.1080/15563650701779703
10.1053/cp.1999.v66.a101462
10.1074/jbc.M601917200
10.1172/JCI1269
10.1097/00002030-200006160-00016
10.1038/aps.2013.69
10.1038/clpt.2011.217
10.1097/00007691-199712000-00001
10.1208/s12248-009-9106-3
10.1038/clpt.2008.102
10.1023/A:1013358126640
10.1038/sj.bjp.0704620
10.2967/jnumed.108.059162
10.1158/0008-5472.CAN-05-2915
10.1124/jpet.102.044388
10.1073/pnas.89.18.8472
10.2165/00003495-200059020-00020
10.1067/mcp.2000.109156
10.1093/jnci/90.15.1161
10.1016/j.clpt.2003.08.011
10.1046/j.0306-5251.2001.01452.x
10.1021/mp050034j
10.1016/j.clpt.2004.02.008
10.1345/aph.1E197
10.1111/j.1365-2125.2009.03396.x
10.1067/mcp.2002.124080
10.1007/s11095-007-9278-4
10.1007/s00210-008-0345-0
10.1038/nrd3028
10.1093/nar/gkp253
10.1212/WNL.0000000000000858
10.1007/s11307-010-0313-1
10.1177/1087057111414896
10.1046/j.1365-2125.2003.01826.x
10.1016/S0021-9258(18)42909-2
10.1200/JCO.2000.18.9.1837
10.1016/S0021-9258(18)71688-8
10.1016/S0021-9258(18)53221-X
10.1128/AAC.42.7.1738
ContentType Journal Article
Copyright Springer Science+Business Media New York 2015
Copyright_xml – notice: Springer Science+Business Media New York 2015
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7RV
7TK
7X7
7XB
88A
88E
8AO
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
CCPQU
D1I
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB.
KB0
LK8
M0S
M1P
M7P
NAPCQ
PDBOC
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s00232-015-9804-y
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Nursing and Allied Health Journals
Neurosciences Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Database (Proquest)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
https://resources.nclive.org/materials
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Nursing & Allied Health Premium
Materials Science Collection
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Central Student
Technology Collection
ProQuest Central Essentials
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
Materials Science Database
ProQuest Medical Library (Alumni)
ProQuest Materials Science Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1432-1424
EndPage 977
ExternalDocumentID 3840938611
10_1007_s00232_015_9804_y
25926125
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
-~X
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
123
199
1N0
1SB
2.D
203
28-
29L
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5VS
67N
67Z
6NX
78A
7RV
7X7
88A
88E
8AO
8FE
8FG
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AANXM
AANZL
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABELW
ABFGW
ABFTV
ABHLI
ABHQN
ABJCF
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABPTK
ABQBU
ABSXP
ABTAH
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACTTH
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADMDM
ADOAH
ADOXG
ADQRH
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AEQTP
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFEXP
AFFNX
AFGCZ
AFKRA
AFLOW
AFNRJ
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
AOSHJ
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBNVY
BBWZM
BDATZ
BENPR
BGLVJ
BGNMA
BHPHI
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
CZ9
D1I
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KB.
KC.
KDC
KOV
KOW
KPH
L7B
LAS
LK8
LLZTM
M0L
M1P
M4Y
M7P
MA-
N2Q
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
PDBOC
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UQL
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WH7
WJK
WK6
WK8
WOW
X7M
XOL
Y6R
YLTOR
Z45
Z7U
Z7V
Z87
Z8O
Z8P
Z91
ZGI
ZMTXR
ZOVNA
ZY4
~EX
~KM
AACDK
AAEOY
AAJBT
AAQLM
AASML
AAYZH
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AIGIU
ALIPV
CGR
CUY
CVF
ECM
EIF
H13
NPM
AAYXX
CITATION
7TK
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c442t-5fd042ab20bc5b45f8e914419b5bbb60fb6382086aadf766066d13b06b6967993
IEDL.DBID BENPR
ISSN 0022-2631
IngestDate Fri Oct 25 02:05:51 EDT 2024
Thu Oct 10 20:09:16 EDT 2024
Thu Sep 12 18:03:16 EDT 2024
Tue Oct 15 23:52:21 EDT 2024
Sat Dec 16 11:59:46 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords MDR1
P-gp
ATPase assay
Vesicular transport assay
ADME
Multidrug resistance transporters
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c442t-5fd042ab20bc5b45f8e914419b5bbb60fb6382086aadf766066d13b06b6967993
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 25926125
PQID 1723543024
PQPubID 48759
PageCount 11
ParticipantIDs proquest_miscellaneous_1725025727
proquest_journals_1723543024
crossref_primary_10_1007_s00232_015_9804_y
pubmed_primary_25926125
springer_journals_10_1007_s00232_015_9804_y
PublicationCentury 2000
PublicationDate 2015-12-01
PublicationDateYYYYMMDD 2015-12-01
PublicationDate_xml – month: 12
  year: 2015
  text: 2015-12-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
– name: Heidelberg
PublicationTitle The Journal of membrane biology
PublicationTitleAbbrev J Membrane Biol
PublicationTitleAlternate J Membr Biol
PublicationYear 2015
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Malingre (CR40) 2001; 85
Meerum Terwogt (CR41) 1999; 5
Speeg, Maldonado, Liaci, Muirhead (CR60) 1992; 261
Clay, Sharom (CR13) 2013; 52
Ambudkar, Lelong, Zhang, Cardarelli, Gottesman, Pastan (CR2) 1992; 89
Jalava, Partanen, Neuvonen (CR30) 1997; 19
Schwab, Fischer, Tabatabaei, Poli, Huwyler (CR55) 2003; 46
Sarkadi, Price, Boucher, Germann, Scarborough (CR52) 1992; 267
Bauer (CR5) 2014; 83
Bihorel, Camenisch, Lemaire, Scherrmann (CR7) 2007; 24
Callies (CR10) 2003; 56
Tidefelt (CR63) 2000; 18
Ding, Tayrouz, Riedel, Burhenne, Weiss, Mikus, Haefeli (CR17) 2004; 76
CR38
von Richter, Glavinas, Krajcsi, Liehner, Siewert, Zech (CR66) 2009; 379
Polli, Wring, Humphreys, Huang, Morgan, Webster, Serabjit-Singh (CR46) 2001; 299
Sadeque, Wandel, He, Shah, Wood (CR49) 2000; 68
Adachi, Suzuki, Sugiyama (CR1) 2001; 18
Hochman, Chiba, Nishime, Yamazaki, Lin (CR27) 2000; 292
Shi (CR57) 2013; 34
Bauer (CR3) 2012; 91
Bentz (CR6) 2013; 41
Simpson, Jarvis (CR58) 2000; 59
Kovarik, Rigaudy, Guerret, Gerbeau, Rost (CR36) 1999; 66
Wang, Hamman, Huang, Lesko, Hall (CR67) 2002; 71
Miyama (CR43) 1998; 42
Kharasch, Hoffer, Whittington, Sheffels (CR33) 2003; 74
Schuetz, Yasuda, Arimori, Schuetz (CR54) 1998; 350
Saeki, Ueda, Tanigawara, Hori, Komano (CR50) 1993; 268
Petri, Tannergren, Rungstad, Lennernas (CR45) 2004; 21
Currier, Ueda, Willingham, Pastan, Gottesman (CR15) 1989; 264
Takano (CR62) 2006; 47
Kawamura (CR32) 2011; 13
Mistry (CR42) 2001; 61
Huisman, Smit, Wiltshire, Beijnen, Schinkel (CR29) 2003; 304
Heredi-Szabo (CR26) 2013; 49
Gupta, Banfield, Kantesaria, Marino, Clement, Affrime, Batra (CR25) 2001; 23
Rollot, Pajot, Chauvelot-Moachon, Nazal, Kelaidi, Blanche (CR47) 2004; 38
Buss, Snell, Bock, Hsu, Jorga (CR9) 2001; 52
Kang, Figg, Ando, Blagosklonny, Liewehr, Fojo, Bates (CR31) 2001; 7
Romermann (CR48) 2013; 40
Sauna, Nandigama, Ambudkar (CR53) 2006; 281
Muzi, Mankoff, Link, Shoner, Collier, Sasongko, Unadkat (CR44) 2009; 50
Hooiveld, Heegsma, van Montfoort, Jansen, Meijer, Muller (CR28) 2002; 135
Bauer (CR4) 2013; 54
Broxterman, Kuiper, Schuurhuis, Tsuruo, Pinedo, Lankelma (CR8) 1988; 37
Kim, Fromm, Wandel, Leake, Wood, Roden, Wilkinson (CR35) 1998; 101
Kharasch, Bedynek, Walker, Whittington, Hoffer (CR34) 2008; 84
van Praag (CR64) 2000; 14
Li, Jin, Kim, Han, Kim, Chung, Shim (CR39) 2008; 25
Collett, Tanianis-Hughes, Hallifax, Warhurst (CR14) 2004; 21
Sziraki (CR61) 2011; 16
Doige, Yu, Sharom (CR18) 1992; 1109
Dantzig (CR16) 1996; 56
Leggas (CR37) 2006; 66
Eleftheriou, Bacis, Fiocchi, Sebastiano (CR19) 2008; 46
Cer, Mudunuri, Stephens, Lebeda (CR11) 2009; 37
Choo (CR12) 2006; 317
CR23
Xia (CR68) 2006; 3
CR22
CR21
Sakugawa, Miura, Hokama, Suzuki, Tateishi, Uno (CR51) 2009; 67
CR20
Smith, Mayer, Schinkel, Borst (CR59) 1998; 90
Schwarz, Gramatte, Krappweis, Oertel, Kirch (CR56) 2000; 38
Zhang, Zhang, Zhao, Huang (CR69) 2009; 11
von Moltke, Granda, Grassi, Perloff, Vishnuvardhan, Greenblatt (CR65) 2004; 32
Giacomini (CR24) 2010; 9
15359574 - Pharm Res. 2004 Aug;21(8):1398-404
19418230 - AAPS J. 2009 Jun;11(2):300-6
9421099 - Ther Drug Monit. 1997 Dec;19(6):609-13
23892274 - Acta Pharmacol Sin. 2013 Oct;34(10):1349-58
18654741 - Pharm Res. 2008 Nov;25(11):2601-12
7681059 - J Biol Chem. 1993 Mar 25;268(9):6077-80
14663457 - Clin Pharmacol Ther. 2003 Dec;74(6):543-54
25186858 - Neurology. 2014 Oct 7;83(15):1326-31
23833270 - J Nucl Med. 2013 Aug;54(8):1181-7
23268645 - Biochemistry. 2013 Jan 15;52(2):343-54
9435299 - J Clin Invest. 1998 Jan 15;101(2):289-94
1355666 - Biochim Biophys Acta. 1992 Aug 24;1109(2):149-60
2898943 - Biochem Pharmacol. 1988 Jun 15;37(12):2389-93
18758752 - Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):11-26
20379788 - Mol Imaging Biol. 2011 Feb;13(1):152-60
23684934 - Eur J Pharm Sci. 2013 Jul 16;49(4):773-81
10784624 - J Clin Oncol. 2000 May;18(9):1837-44
15180340 - Pharm Res. 2004 May;21(5):819-26
15229466 - Clin Pharmacol Ther. 2004 Jul;76(1):73-84
19617341 - J Nucl Med. 2009 Aug;50(8):1267-75
1347044 - J Biol Chem. 1992 Mar 5;267(7):4854-8
8797588 - Cancer Res. 1996 Sep 15;56(18):4171-9
12538811 - J Pharmacol Exp Ther. 2003 Feb;304(2):596-602
11318079 - Clin Ther. 2001 Mar;23(3):451-66
11212278 - Cancer Res. 2001 Jan 15;61(2):749-58
16651435 - Cancer Res. 2006 May 1;66(9):4802-7
9473310 - Arch Biochem Biophys. 1998 Feb 15;350(2):340-7
10546923 - Clin Pharmacol Ther. 1999 Oct;66(4):391-400
16686372 - Mol Pharm. 2006 Jan-Feb;3(1):78-86
10730552 - Drugs. 2000 Feb;59(2):301-21
19238656 - Clin Pharmacol Ther. 2008 Oct;84(4):506-12
10604964 - J Pharmacol Exp Ther. 2000 Jan;292(1):310-8
15494379 - Ann Pharmacother. 2004 Dec;38(12):2074-7
11720431 - Br J Cancer. 2001 Nov 16;85(10):1472-7
19552748 - Br J Clin Pharmacol. 2009 May;67(5):535-40
18608282 - Clin Toxicol (Phila). 2008 Nov;46(9):827-30
22166851 - Clin Pharmacol Ther. 2012 Feb;91(2):227-33
7912531 - J Natl Cancer Inst Monogr. 1993;(15):63-7
23620485 - Drug Metab Dispos. 2013 Jul;41(7):1347-66
12699389 - J Med Chem. 2003 Apr 24;46(9):1716-25
9661014 - Antimicrob Agents Chemother. 1998 Jul;42(7):1738-44
1356264 - Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8472-6
16844693 - J Biol Chem. 2006 Sep 8;281(36):26501-11
12848775 - Br J Clin Pharmacol. 2003 Jul;56(1):46-56
11785684 - Pharm Res. 2001 Dec;18(12):1660-8
20190787 - Nat Rev Drug Discov. 2010 Mar;9(3):215-36
11934808 - Br J Pharmacol. 2002 Apr;135(7):1685-94
1348538 - J Pharmacol Exp Ther. 1992 Apr;261(1):50-5
15258104 - Drug Metab Dispos. 2004 Aug;32(8):800-4
10894283 - AIDS. 2000 Jun 16;14(9):1187-94
17380257 - Pharm Res. 2007 Sep;24(9):1720-8
10783825 - Int J Clin Pharmacol Ther. 2000 Apr;38(4):161-7
11410497 - Clin Cancer Res. 2001 Jun;7(6):1610-7
9701366 - J Natl Cancer Inst. 1998 Aug 5;90(15):1161-6
19395593 - Nucleic Acids Res. 2009 Jul;37(Web Server issue):W441-5
11560557 - Br J Clin Pharmacol. 2001 Sep;52(3):255-64
12087344 - Clin Pharmacol Ther. 2002 Jun;71(6):414-20
10589748 - Clin Cancer Res. 1999 Nov;5(11):3379-84
11602674 - J Pharmacol Exp Ther. 2001 Nov;299(2):620-8
2569468 - J Biol Chem. 1989 Aug 25;264(24):14376-81
11014404 - Clin Pharmacol Ther. 2000 Sep;68(3):231-7
21832259 - J Biomol Screen. 2011 Sep;16(8):886-94
23845421 - Nucl Med Biol. 2013 Oct;40(7):873-8
16537797 - J Pharmacol Exp Ther. 2006 Jun;317(3):1012-8
16954549 - J Nucl Med. 2006 Sep;47(9):1427-33
KV Speeg (9804_CR60) 1992; 261
K Romermann (9804_CR48) 2013; 40
9804_CR20
P Mistry (9804_CR42) 2001; 61
U Tidefelt (9804_CR63) 2000; 18
9804_CR21
9804_CR22
JH Hochman (9804_CR27) 2000; 292
9804_CR23
M Muzi (9804_CR44) 2009; 50
B Sarkadi (9804_CR52) 1992; 267
KM Giacomini (9804_CR24) 2010; 9
I Sziraki (9804_CR61) 2011; 16
N Petri (9804_CR45) 2004; 21
S Bihorel (9804_CR7) 2007; 24
ED Kharasch (9804_CR33) 2003; 74
D Schwab (9804_CR55) 2003; 46
H Li (9804_CR39) 2008; 25
M Leggas (9804_CR37) 2006; 66
K Kawamura (9804_CR32) 2011; 13
R Ding (9804_CR17) 2004; 76
K Simpson (9804_CR58) 2000; 59
CA Doige (9804_CR18) 1992; 1109
MT Huisman (9804_CR29) 2003; 304
M Bauer (9804_CR5) 2014; 83
GJ Hooiveld (9804_CR28) 2002; 135
AT Clay (9804_CR13) 2013; 52
A Collett (9804_CR14) 2004; 21
9804_CR38
RB Kim (9804_CR35) 1998; 101
J Shi (9804_CR57) 2013; 34
T Saeki (9804_CR50) 1993; 268
T Miyama (9804_CR43) 1998; 42
UI Schwarz (9804_CR56) 2000; 38
Z Wang (9804_CR67) 2002; 71
ZE Sauna (9804_CR53) 2006; 281
M Bauer (9804_CR4) 2013; 54
HJ Broxterman (9804_CR8) 1988; 37
O Richter von (9804_CR66) 2009; 379
MH Kang (9804_CR31) 2001; 7
S Callies (9804_CR10) 2003; 56
ED Kharasch (9804_CR34) 2008; 84
K Heredi-Szabo (9804_CR26) 2013; 49
CQ Xia (9804_CR68) 2006; 3
L Zhang (9804_CR69) 2009; 11
RM Praag van (9804_CR64) 2000; 14
RZ Cer (9804_CR11) 2009; 37
AJ Sadeque (9804_CR49) 2000; 68
Y Adachi (9804_CR1) 2001; 18
S Gupta (9804_CR25) 2001; 23
KM Jalava (9804_CR30) 1997; 19
LL Moltke von (9804_CR65) 2004; 32
JW Polli (9804_CR46) 2001; 299
G Eleftheriou (9804_CR19) 2008; 46
JM Kovarik (9804_CR36) 1999; 66
MM Malingre (9804_CR40) 2001; 85
T Sakugawa (9804_CR51) 2009; 67
AJ Smith (9804_CR59) 1998; 90
F Rollot (9804_CR47) 2004; 38
JM Meerum Terwogt (9804_CR41) 1999; 5
A Takano (9804_CR62) 2006; 47
N Buss (9804_CR9) 2001; 52
SJ Currier (9804_CR15) 1989; 264
AH Dantzig (9804_CR16) 1996; 56
EG Schuetz (9804_CR54) 1998; 350
SV Ambudkar (9804_CR2) 1992; 89
EF Choo (9804_CR12) 2006; 317
M Bauer (9804_CR3) 2012; 91
J Bentz (9804_CR6) 2013; 41
References_xml – ident: CR22
– volume: 261
  start-page: 50
  year: 1992
  end-page: 55
  ident: CR60
  article-title: Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: Muirhead
– volume: 46
  start-page: 1716
  year: 2003
  end-page: 1725
  ident: CR55
  article-title: Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery
  publication-title: J Med Chem
  doi: 10.1021/jm021012t
  contributor:
    fullname: Huwyler
– volume: 317
  start-page: 1012
  year: 2006
  end-page: 1018
  ident: CR12
  article-title: Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood–brain barrier
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.105.099648
  contributor:
    fullname: Choo
– volume: 268
  start-page: 6077
  year: 1993
  end-page: 6080
  ident: CR50
  article-title: Human P-glycoprotein transports cyclosporin A and FK506
  publication-title: J Biol Chem
  contributor:
    fullname: Komano
– volume: 21
  start-page: 1398
  year: 2004
  end-page: 1404
  ident: CR45
  article-title: Transport characteristics of fexofenadine in the Caco-2 cell model
  publication-title: Pharm Res
  doi: 10.1023/B:PHAM.0000036913.90332.b1
  contributor:
    fullname: Lennernas
– volume: 49
  start-page: 773
  year: 2013
  end-page: 781
  ident: CR26
  article-title: A P-gp vesicular transport inhibition assay—optimization and validation for drug–drug interaction testing
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2013.04.032
  contributor:
    fullname: Heredi-Szabo
– volume: 23
  start-page: 451
  year: 2001
  end-page: 466
  ident: CR25
  article-title: Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study
  publication-title: Clin Ther
  doi: 10.1016/S0149-2918(01)80049-7
  contributor:
    fullname: Batra
– volume: 350
  start-page: 340
  year: 1998
  end-page: 347
  ident: CR54
  article-title: Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene
  publication-title: Arch Biochem Biophys
  doi: 10.1006/abbi.1997.0537
  contributor:
    fullname: Schuetz
– volume: 25
  start-page: 2601
  year: 2008
  end-page: 2612
  ident: CR39
  article-title: Involvement of P-glycoprotein, multidrug resistance protein 2 and breast cancer resistance protein in the transport of belotecan and topotecan in Caco-2 and MDCKII cells
  publication-title: Pharm Res
  doi: 10.1007/s11095-008-9678-0
  contributor:
    fullname: Shim
– volume: 85
  start-page: 1472
  year: 2001
  end-page: 1477
  ident: CR40
  article-title: The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients
  publication-title: Br J Cancer
  doi: 10.1054/bjoc.2001.2118
  contributor:
    fullname: Malingre
– volume: 37
  start-page: 2389
  year: 1988
  end-page: 2393
  ident: CR8
  article-title: Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein
  publication-title: Biochem Pharmacol
  doi: 10.1016/0006-2952(88)90365-6
  contributor:
    fullname: Lankelma
– volume: 21
  start-page: 819
  year: 2004
  end-page: 826
  ident: CR14
  article-title: Predicting P-glycoprotein effects on oral absorption: correlation of transport in Caco-2 with drug pharmacokinetics in wild-type and mdr1a(−/−) mice in vivo
  publication-title: Pharm Res
  doi: 10.1023/B:PHAM.0000026434.82855.69
  contributor:
    fullname: Warhurst
– volume: 40
  start-page: 873
  year: 2013
  end-page: 878
  ident: CR48
  article-title: (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood–brain barrier, and not by MRP1 and BCRP
  publication-title: Nucl Med Biol
  doi: 10.1016/j.nucmedbio.2013.05.012
  contributor:
    fullname: Romermann
– ident: CR21
– volume: 38
  start-page: 161
  year: 2000
  end-page: 167
  ident: CR56
  article-title: P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans
  publication-title: Int J Clin Pharmacol Ther
  doi: 10.5414/CPP38161
  contributor:
    fullname: Kirch
– volume: 52
  start-page: 343
  year: 2013
  end-page: 354
  ident: CR13
  article-title: Lipid bilayer properties control membrane partitioning, binding, and transport of p-glycoprotein substrates
  publication-title: Biochemistry
  doi: 10.1021/bi301532c
  contributor:
    fullname: Sharom
– volume: 41
  start-page: 1347
  year: 2013
  end-page: 1366
  ident: CR6
  article-title: Variability in P-glycoprotein inhibitory potency (IC(5)(0)) using various in vitro experimental systems: implications for universal digoxin drug–drug interaction risk assessment decision criteria
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.112.050500
  contributor:
    fullname: Bentz
– volume: 54
  start-page: 1181
  year: 2013
  end-page: 1187
  ident: CR4
  article-title: Interaction of 11C-tariquidar and 11C-elacridar with P-glycoprotein and breast cancer resistance protein at the human blood–brain barrier
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.112.118232
  contributor:
    fullname: Bauer
– volume: 18
  start-page: 1837
  year: 2000
  end-page: 1844
  ident: CR63
  article-title: P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia
  publication-title: J Clin Oncol
  contributor:
    fullname: Tidefelt
– volume: 1109
  start-page: 149
  year: 1992
  end-page: 160
  ident: CR18
  article-title: ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0005-2736(92)90078-Z
  contributor:
    fullname: Sharom
– volume: 32
  start-page: 800
  year: 2004
  end-page: 804
  ident: CR65
  article-title: Interaction of triazolam and ketoconazole in P-glycoprotein-deficient mice
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.32.8.800
  contributor:
    fullname: Greenblatt
– volume: 46
  start-page: 827
  year: 2008
  end-page: 830
  ident: CR19
  article-title: Colchicine-induced toxicity in a heart transplant patient with chronic renal failure
  publication-title: Clin Toxicol (Phila)
  doi: 10.1080/15563650701779703
  contributor:
    fullname: Sebastiano
– volume: 66
  start-page: 391
  year: 1999
  end-page: 400
  ident: CR36
  article-title: Longitudinal assessment of a P-glycoprotein-mediated drug interaction of valspodar on digoxin
  publication-title: Clin Pharmacol Ther
  doi: 10.1053/cp.1999.v66.a101462
  contributor:
    fullname: Rost
– volume: 281
  start-page: 26501
  year: 2006
  end-page: 26511
  ident: CR53
  article-title: Exploiting reaction intermediates of the ATPase reaction to elucidate the mechanism of transport by P-glycoprotein (ABCB1)
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M601917200
  contributor:
    fullname: Ambudkar
– volume: 101
  start-page: 289
  year: 1998
  end-page: 294
  ident: CR35
  article-title: The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
  publication-title: J Clin Invest
  doi: 10.1172/JCI1269
  contributor:
    fullname: Wilkinson
– volume: 14
  start-page: 1187
  year: 2000
  end-page: 1194
  ident: CR64
  article-title: Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir
  publication-title: AIDS
  doi: 10.1097/00002030-200006160-00016
  contributor:
    fullname: van Praag
– volume: 264
  start-page: 14376
  year: 1989
  end-page: 14381
  ident: CR15
  article-title: Deletion and insertion mutants of the multidrug transporter
  publication-title: J Biol Chem
  contributor:
    fullname: Gottesman
– volume: 292
  start-page: 310
  year: 2000
  end-page: 318
  ident: CR27
  article-title: Influence of P-glycoprotein on the transport and metabolism of indinavir in Caco-2 cells expressing cytochrome P-450 3A4
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: Lin
– volume: 47
  start-page: 1427
  year: 2006
  end-page: 1433
  ident: CR62
  article-title: Evaluation of in vivo P-glycoprotein function at the blood–brain barrier among MDR1 gene polymorphisms by using 11C-verapamil
  publication-title: J Nucl Med
  contributor:
    fullname: Takano
– volume: 34
  start-page: 1349
  year: 2013
  end-page: 1358
  ident: CR57
  article-title: Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2013.69
  contributor:
    fullname: Shi
– volume: 91
  start-page: 227
  year: 2012
  end-page: 233
  ident: CR3
  article-title: Pgp-mediated interaction between (R)-[11C]verapamil and tariquidar at the human blood–brain barrier: a comparison with rat data
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2011.217
  contributor:
    fullname: Bauer
– volume: 19
  start-page: 609
  year: 1997
  end-page: 613
  ident: CR30
  article-title: Itraconazole decreases renal clearance of digoxin
  publication-title: Ther Drug Monit
  doi: 10.1097/00007691-199712000-00001
  contributor:
    fullname: Neuvonen
– volume: 11
  start-page: 300
  year: 2009
  end-page: 306
  ident: CR69
  article-title: Predicting drug–drug interactions: an FDA perspective
  publication-title: AAPS J
  doi: 10.1208/s12248-009-9106-3
  contributor:
    fullname: Huang
– volume: 84
  start-page: 506
  year: 2008
  end-page: 512
  ident: CR34
  article-title: Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: II. Ritonavir effects on CYP3A and P-glycoprotein activities
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2008.102
  contributor:
    fullname: Hoffer
– volume: 18
  start-page: 1660
  year: 2001
  end-page: 1668
  ident: CR1
  article-title: Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein
  publication-title: Pharm Res
  doi: 10.1023/A:1013358126640
  contributor:
    fullname: Sugiyama
– volume: 135
  start-page: 1685
  year: 2002
  end-page: 1694
  ident: CR28
  article-title: Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0704620
  contributor:
    fullname: Muller
– volume: 50
  start-page: 1267
  year: 2009
  end-page: 1275
  ident: CR44
  article-title: Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humans
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.108.059162
  contributor:
    fullname: Unadkat
– volume: 66
  start-page: 4802
  year: 2006
  end-page: 4807
  ident: CR37
  article-title: Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-2915
  contributor:
    fullname: Leggas
– volume: 304
  start-page: 596
  year: 2003
  end-page: 602
  ident: CR29
  article-title: Assessing safety and efficacy of directed P-glycoprotein inhibition to improve the pharmacokinetic properties of saquinavir coadministered with ritonavir
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.102.044388
  contributor:
    fullname: Schinkel
– volume: 89
  start-page: 8472
  year: 1992
  end-page: 8476
  ident: CR2
  article-title: Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.89.18.8472
  contributor:
    fullname: Pastan
– volume: 59
  start-page: 301
  year: 2000
  end-page: 321
  ident: CR58
  article-title: Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria
  publication-title: Drugs
  doi: 10.2165/00003495-200059020-00020
  contributor:
    fullname: Jarvis
– volume: 56
  start-page: 4171
  year: 1996
  end-page: 4179
  ident: CR16
  article-title: Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979
  publication-title: Cancer Res
  contributor:
    fullname: Dantzig
– volume: 68
  start-page: 231
  year: 2000
  end-page: 237
  ident: CR49
  article-title: Increased drug delivery to the brain by P-glycoprotein inhibition
  publication-title: Clin Pharmacol Ther
  doi: 10.1067/mcp.2000.109156
  contributor:
    fullname: Wood
– volume: 90
  start-page: 1161
  year: 1998
  end-page: 1166
  ident: CR59
  article-title: Availability of PSC833, a substrate and inhibitor of P-glycoproteins, in various concentrations of serum
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/90.15.1161
  contributor:
    fullname: Borst
– volume: 74
  start-page: 543
  year: 2003
  end-page: 554
  ident: CR33
  article-title: Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine
  publication-title: Clin Pharmacol Ther
  doi: 10.1016/j.clpt.2003.08.011
  contributor:
    fullname: Sheffels
– volume: 52
  start-page: 255
  year: 2001
  end-page: 264
  ident: CR9
  article-title: Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.0306-5251.2001.01452.x
  contributor:
    fullname: Jorga
– volume: 7
  start-page: 1610
  year: 2001
  end-page: 1617
  ident: CR31
  article-title: The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel
  publication-title: Clin Cancer Res
  contributor:
    fullname: Bates
– volume: 267
  start-page: 4854
  year: 1992
  end-page: 4858
  ident: CR52
  article-title: Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase
  publication-title: J Biol Chem
  contributor:
    fullname: Scarborough
– volume: 3
  start-page: 78
  year: 2006
  end-page: 86
  ident: CR68
  article-title: Comparison of species differences of P-glycoproteins in beagle dog, rhesus monkey, and human using Atpase activity assays
  publication-title: Mol Pharm
  doi: 10.1021/mp050034j
  contributor:
    fullname: Xia
– volume: 76
  start-page: 73
  year: 2004
  end-page: 84
  ident: CR17
  article-title: Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers
  publication-title: Clin Pharmacol Ther
  doi: 10.1016/j.clpt.2004.02.008
  contributor:
    fullname: Haefeli
– volume: 38
  start-page: 2074
  year: 2004
  end-page: 2077
  ident: CR47
  article-title: Acute colchicine intoxication during clarithromycin administration
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1E197
  contributor:
    fullname: Blanche
– volume: 67
  start-page: 535
  year: 2009
  end-page: 540
  ident: CR51
  article-title: Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil
  publication-title: Br J Clin Pharmacol
  doi: 10.1111/j.1365-2125.2009.03396.x
  contributor:
    fullname: Uno
– volume: 71
  start-page: 414
  year: 2002
  end-page: 420
  ident: CR67
  article-title: Effect of St John’s wort on the pharmacokinetics of fexofenadine
  publication-title: Clin Pharmacol Ther
  doi: 10.1067/mcp.2002.124080
  contributor:
    fullname: Hall
– volume: 24
  start-page: 1720
  year: 2007
  end-page: 1728
  ident: CR7
  article-title: Modulation of the brain distribution of imatinib and its metabolites in mice by valspodar, zosuquidar and elacridar
  publication-title: Pharm Res
  doi: 10.1007/s11095-007-9278-4
  contributor:
    fullname: Scherrmann
– volume: 379
  start-page: 11
  year: 2009
  end-page: 26
  ident: CR66
  article-title: A novel screening strategy to identify ABCB1 substrates and inhibitors
  publication-title: Naunyn Schmiedebergs Arch Pharmacol
  doi: 10.1007/s00210-008-0345-0
  contributor:
    fullname: Zech
– ident: CR23
– volume: 61
  start-page: 749
  year: 2001
  end-page: 758
  ident: CR42
  article-title: In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576
  publication-title: Cancer Res
  contributor:
    fullname: Mistry
– volume: 9
  start-page: 215
  year: 2010
  end-page: 236
  ident: CR24
  article-title: Membrane transporters in drug development
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd3028
  contributor:
    fullname: Giacomini
– volume: 5
  start-page: 3379
  year: 1999
  end-page: 3384
  ident: CR41
  article-title: Coadministration of oral cyclosporin A enables oral therapy with paclitaxel
  publication-title: Clin Cancer Res
  contributor:
    fullname: Meerum Terwogt
– volume: 37
  start-page: W441
  year: 2009
  end-page: W445
  ident: CR11
  article-title: IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkp253
  contributor:
    fullname: Lebeda
– volume: 299
  start-page: 620
  year: 2001
  end-page: 628
  ident: CR46
  article-title: Rational use of in vitro P-glycoprotein assays in drug discovery
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: Serabjit-Singh
– ident: CR38
– volume: 83
  start-page: 1326
  year: 2014
  end-page: 1331
  ident: CR5
  article-title: In vivo P-glycoprotein function before and after epilepsy surgery
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000000858
  contributor:
    fullname: Bauer
– volume: 13
  start-page: 152
  year: 2011
  end-page: 160
  ident: CR32
  article-title: Evaluation of limiting brain penetration related to P-glycoprotein and breast cancer resistance protein using [(11)C]GF120918 by PET in mice
  publication-title: Mol Imaging Biol
  doi: 10.1007/s11307-010-0313-1
  contributor:
    fullname: Kawamura
– volume: 42
  start-page: 1738
  year: 1998
  end-page: 1744
  ident: CR43
  article-title: P-glycoprotein-mediated transport of itraconazole across the blood–brain barrier
  publication-title: Antimicrob Agents Chemother
  contributor:
    fullname: Miyama
– volume: 16
  start-page: 886
  year: 2011
  end-page: 894
  ident: CR61
  article-title: Quinidine as an ABCB1 probe for testing drug interactions at the blood–brain barrier: an in vitro in vivo correlation study
  publication-title: J Biomol Screen
  doi: 10.1177/1087057111414896
  contributor:
    fullname: Sziraki
– volume: 56
  start-page: 46
  year: 2003
  end-page: 56
  ident: CR10
  article-title: A population pharmacokinetic model for paclitaxel in the presence of a novel P-gp modulator, Zosuquidar Trihydrochloride (LY335979)
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.1365-2125.2003.01826.x
  contributor:
    fullname: Callies
– ident: CR20
– volume: 18
  start-page: 1660
  year: 2001
  ident: 9804_CR1
  publication-title: Pharm Res
  doi: 10.1023/A:1013358126640
  contributor:
    fullname: Y Adachi
– volume: 267
  start-page: 4854
  year: 1992
  ident: 9804_CR52
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)42909-2
  contributor:
    fullname: B Sarkadi
– volume: 34
  start-page: 1349
  year: 2013
  ident: 9804_CR57
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2013.69
  contributor:
    fullname: J Shi
– volume: 299
  start-page: 620
  year: 2001
  ident: 9804_CR46
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: JW Polli
– volume: 89
  start-page: 8472
  year: 1992
  ident: 9804_CR2
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.89.18.8472
  contributor:
    fullname: SV Ambudkar
– volume: 38
  start-page: 2074
  year: 2004
  ident: 9804_CR47
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1E197
  contributor:
    fullname: F Rollot
– volume: 32
  start-page: 800
  year: 2004
  ident: 9804_CR65
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.32.8.800
  contributor:
    fullname: LL Moltke von
– volume: 5
  start-page: 3379
  year: 1999
  ident: 9804_CR41
  publication-title: Clin Cancer Res
  contributor:
    fullname: JM Meerum Terwogt
– volume: 281
  start-page: 26501
  year: 2006
  ident: 9804_CR53
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M601917200
  contributor:
    fullname: ZE Sauna
– volume: 350
  start-page: 340
  year: 1998
  ident: 9804_CR54
  publication-title: Arch Biochem Biophys
  doi: 10.1006/abbi.1997.0537
  contributor:
    fullname: EG Schuetz
– volume: 52
  start-page: 255
  year: 2001
  ident: 9804_CR9
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.0306-5251.2001.01452.x
  contributor:
    fullname: N Buss
– volume: 54
  start-page: 1181
  year: 2013
  ident: 9804_CR4
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.112.118232
  contributor:
    fullname: M Bauer
– volume: 41
  start-page: 1347
  year: 2013
  ident: 9804_CR6
  publication-title: Drug Metab Dispos
  doi: 10.1124/dmd.112.050500
  contributor:
    fullname: J Bentz
– volume: 1109
  start-page: 149
  year: 1992
  ident: 9804_CR18
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0005-2736(92)90078-Z
  contributor:
    fullname: CA Doige
– volume: 91
  start-page: 227
  year: 2012
  ident: 9804_CR3
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2011.217
  contributor:
    fullname: M Bauer
– volume: 49
  start-page: 773
  year: 2013
  ident: 9804_CR26
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2013.04.032
  contributor:
    fullname: K Heredi-Szabo
– volume: 61
  start-page: 749
  year: 2001
  ident: 9804_CR42
  publication-title: Cancer Res
  contributor:
    fullname: P Mistry
– ident: 9804_CR22
– volume: 47
  start-page: 1427
  year: 2006
  ident: 9804_CR62
  publication-title: J Nucl Med
  contributor:
    fullname: A Takano
– volume: 66
  start-page: 4802
  year: 2006
  ident: 9804_CR37
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-2915
  contributor:
    fullname: M Leggas
– volume: 85
  start-page: 1472
  year: 2001
  ident: 9804_CR40
  publication-title: Br J Cancer
  doi: 10.1054/bjoc.2001.2118
  contributor:
    fullname: MM Malingre
– volume: 7
  start-page: 1610
  year: 2001
  ident: 9804_CR31
  publication-title: Clin Cancer Res
  contributor:
    fullname: MH Kang
– volume: 18
  start-page: 1837
  year: 2000
  ident: 9804_CR63
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2000.18.9.1837
  contributor:
    fullname: U Tidefelt
– volume: 37
  start-page: 2389
  year: 1988
  ident: 9804_CR8
  publication-title: Biochem Pharmacol
  doi: 10.1016/0006-2952(88)90365-6
  contributor:
    fullname: HJ Broxterman
– volume: 14
  start-page: 1187
  year: 2000
  ident: 9804_CR64
  publication-title: AIDS
  doi: 10.1097/00002030-200006160-00016
  contributor:
    fullname: RM Praag van
– volume: 21
  start-page: 1398
  year: 2004
  ident: 9804_CR45
  publication-title: Pharm Res
  doi: 10.1023/B:PHAM.0000036913.90332.b1
  contributor:
    fullname: N Petri
– volume: 13
  start-page: 152
  year: 2011
  ident: 9804_CR32
  publication-title: Mol Imaging Biol
  doi: 10.1007/s11307-010-0313-1
  contributor:
    fullname: K Kawamura
– volume: 25
  start-page: 2601
  year: 2008
  ident: 9804_CR39
  publication-title: Pharm Res
  doi: 10.1007/s11095-008-9678-0
  contributor:
    fullname: H Li
– volume: 66
  start-page: 391
  year: 1999
  ident: 9804_CR36
  publication-title: Clin Pharmacol Ther
  doi: 10.1053/cp.1999.v66.a101462
  contributor:
    fullname: JM Kovarik
– volume: 21
  start-page: 819
  year: 2004
  ident: 9804_CR14
  publication-title: Pharm Res
  doi: 10.1023/B:PHAM.0000026434.82855.69
  contributor:
    fullname: A Collett
– ident: 9804_CR21
– volume: 101
  start-page: 289
  year: 1998
  ident: 9804_CR35
  publication-title: J Clin Invest
  doi: 10.1172/JCI1269
  contributor:
    fullname: RB Kim
– volume: 3
  start-page: 78
  year: 2006
  ident: 9804_CR68
  publication-title: Mol Pharm
  doi: 10.1021/mp050034j
  contributor:
    fullname: CQ Xia
– volume: 264
  start-page: 14376
  year: 1989
  ident: 9804_CR15
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)71688-8
  contributor:
    fullname: SJ Currier
– volume: 268
  start-page: 6077
  year: 1993
  ident: 9804_CR50
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)53221-X
  contributor:
    fullname: T Saeki
– volume: 56
  start-page: 4171
  year: 1996
  ident: 9804_CR16
  publication-title: Cancer Res
  contributor:
    fullname: AH Dantzig
– volume: 261
  start-page: 50
  year: 1992
  ident: 9804_CR60
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: KV Speeg
– volume: 74
  start-page: 543
  year: 2003
  ident: 9804_CR33
  publication-title: Clin Pharmacol Ther
  doi: 10.1016/j.clpt.2003.08.011
  contributor:
    fullname: ED Kharasch
– volume: 68
  start-page: 231
  year: 2000
  ident: 9804_CR49
  publication-title: Clin Pharmacol Ther
  doi: 10.1067/mcp.2000.109156
  contributor:
    fullname: AJ Sadeque
– volume: 9
  start-page: 215
  year: 2010
  ident: 9804_CR24
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd3028
  contributor:
    fullname: KM Giacomini
– volume: 23
  start-page: 451
  year: 2001
  ident: 9804_CR25
  publication-title: Clin Ther
  doi: 10.1016/S0149-2918(01)80049-7
  contributor:
    fullname: S Gupta
– volume: 317
  start-page: 1012
  year: 2006
  ident: 9804_CR12
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.105.099648
  contributor:
    fullname: EF Choo
– volume: 50
  start-page: 1267
  year: 2009
  ident: 9804_CR44
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.108.059162
  contributor:
    fullname: M Muzi
– volume: 304
  start-page: 596
  year: 2003
  ident: 9804_CR29
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.102.044388
  contributor:
    fullname: MT Huisman
– volume: 46
  start-page: 1716
  year: 2003
  ident: 9804_CR55
  publication-title: J Med Chem
  doi: 10.1021/jm021012t
  contributor:
    fullname: D Schwab
– volume: 16
  start-page: 886
  year: 2011
  ident: 9804_CR61
  publication-title: J Biomol Screen
  doi: 10.1177/1087057111414896
  contributor:
    fullname: I Sziraki
– volume: 56
  start-page: 46
  year: 2003
  ident: 9804_CR10
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.1365-2125.2003.01826.x
  contributor:
    fullname: S Callies
– ident: 9804_CR20
– volume: 90
  start-page: 1161
  year: 1998
  ident: 9804_CR59
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/90.15.1161
  contributor:
    fullname: AJ Smith
– volume: 38
  start-page: 161
  year: 2000
  ident: 9804_CR56
  publication-title: Int J Clin Pharmacol Ther
  doi: 10.5414/CPP38161
  contributor:
    fullname: UI Schwarz
– volume: 83
  start-page: 1326
  year: 2014
  ident: 9804_CR5
  publication-title: Neurology
  doi: 10.1212/WNL.0000000000000858
  contributor:
    fullname: M Bauer
– volume: 84
  start-page: 506
  year: 2008
  ident: 9804_CR34
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.2008.102
  contributor:
    fullname: ED Kharasch
– volume: 67
  start-page: 535
  year: 2009
  ident: 9804_CR51
  publication-title: Br J Clin Pharmacol
  doi: 10.1111/j.1365-2125.2009.03396.x
  contributor:
    fullname: T Sakugawa
– volume: 379
  start-page: 11
  year: 2009
  ident: 9804_CR66
  publication-title: Naunyn Schmiedebergs Arch Pharmacol
  doi: 10.1007/s00210-008-0345-0
  contributor:
    fullname: O Richter von
– volume: 24
  start-page: 1720
  year: 2007
  ident: 9804_CR7
  publication-title: Pharm Res
  doi: 10.1007/s11095-007-9278-4
  contributor:
    fullname: S Bihorel
– volume: 76
  start-page: 73
  year: 2004
  ident: 9804_CR17
  publication-title: Clin Pharmacol Ther
  doi: 10.1016/j.clpt.2004.02.008
  contributor:
    fullname: R Ding
– volume: 292
  start-page: 310
  year: 2000
  ident: 9804_CR27
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: JH Hochman
– ident: 9804_CR38
– volume: 52
  start-page: 343
  year: 2013
  ident: 9804_CR13
  publication-title: Biochemistry
  doi: 10.1021/bi301532c
  contributor:
    fullname: AT Clay
– volume: 135
  start-page: 1685
  year: 2002
  ident: 9804_CR28
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0704620
  contributor:
    fullname: GJ Hooiveld
– volume: 19
  start-page: 609
  year: 1997
  ident: 9804_CR30
  publication-title: Ther Drug Monit
  doi: 10.1097/00007691-199712000-00001
  contributor:
    fullname: KM Jalava
– volume: 37
  start-page: W441
  year: 2009
  ident: 9804_CR11
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkp253
  contributor:
    fullname: RZ Cer
– volume: 42
  start-page: 1738
  year: 1998
  ident: 9804_CR43
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.42.7.1738
  contributor:
    fullname: T Miyama
– volume: 71
  start-page: 414
  year: 2002
  ident: 9804_CR67
  publication-title: Clin Pharmacol Ther
  doi: 10.1067/mcp.2002.124080
  contributor:
    fullname: Z Wang
– volume: 11
  start-page: 300
  year: 2009
  ident: 9804_CR69
  publication-title: AAPS J
  doi: 10.1208/s12248-009-9106-3
  contributor:
    fullname: L Zhang
– ident: 9804_CR23
– volume: 59
  start-page: 301
  year: 2000
  ident: 9804_CR58
  publication-title: Drugs
  doi: 10.2165/00003495-200059020-00020
  contributor:
    fullname: K Simpson
– volume: 40
  start-page: 873
  year: 2013
  ident: 9804_CR48
  publication-title: Nucl Med Biol
  doi: 10.1016/j.nucmedbio.2013.05.012
  contributor:
    fullname: K Romermann
– volume: 46
  start-page: 827
  year: 2008
  ident: 9804_CR19
  publication-title: Clin Toxicol (Phila)
  doi: 10.1080/15563650701779703
  contributor:
    fullname: G Eleftheriou
SSID ssj0017764
Score 2.2153952
Snippet ATP-binding cassette sub-family B member 1 (ABCB1) [P-glycoprotein (P-gp), multidrug resistance protein 1 (MDR1)] can affect the pharmacokinetics, safety, and...
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 967
SubjectTerms Adenosine triphosphatase
Adenosine Triphosphatases - antagonists & inhibitors
Adenosine Triphosphatases - metabolism
Animals
ATP Binding Cassette Transporter, Sub-Family B - antagonists & inhibitors
ATP Binding Cassette Transporter, Sub-Family B - metabolism
Biochemistry
Biological Transport
Biomedical and Life Sciences
Cell Line
Cell Membrane - metabolism
Colchicine - pharmacology
Dose-Response Relationship, Drug
Drug resistance
Drug therapy
Enzyme Activation
Human Physiology
Humans
Inhibitory Concentration 50
Kinetics
Life Sciences
Membranes
Paclitaxel - pharmacology
Proteins
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV07T8MwED6VIiQWxJtAQUZiAgUlfiWZUClUFVKZqMQW2bXNgEhRH0P59ZyTJgIBA3McJ_p85_vO9zDAheKMMWvTUBjDQ265CbUv9mGKxiaTSrOyO__wUQ5G_OFZPLeANkcXxet1HZEsN-qm1s1bF59FIMIsjXi4XIN15A7cp3GNaLeJHCSJ5HWHcCpZXEcyf5viuy36QTB_BEdLm9Pfhq0VWSTdanV3oGWLXdioro9c7sHN0L6hs1tYgiCr5YzMJ6TXNGD-sKQ87qsqF8jEkbvp4mVG_Mkr6d72buN9GPXvn3qDcHUhQjjmnM5D4QzqmNI00mOhuXCpzbxDlGmhtZaR06hNFJ0UpYxLpPdNTMx0JLXMZIJM5ADaxaSwR0CMi5TSaeooN9xxnaUG3xex02OJFj0J4LKGJn-v-l7kTYfjEsccccw9jvkygE4NXr5SgVmOzIgJzpADBHDePEbh9REJhGayKMcIJF3IoQI4rEBvvoZ-mW9vJgK4qlfhy-R__crxv0afwCb14lCmp3SgPZ8u7CmSjLk-K6XqE5wCxnM
  priority: 102
  providerName: Springer Nature
Title Membrane Assays to Characterize Interaction of Drugs with ABCB1
URI https://link.springer.com/article/10.1007/s00232-015-9804-y
https://www.ncbi.nlm.nih.gov/pubmed/25926125
https://www.proquest.com/docview/1723543024
https://search.proquest.com/docview/1725025727
Volume 248
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT9swFH-CVpN2QRv7IMAqT9ppk7XEX0lOqC0tiAk0TavUnSK7tjnRAG0P5a_nOV_bhOCSQ-Ik1u_Zfl_27wF80YJz7lxGpbWCCicsNeGwD9cssbnShlfs_JdX6nwmLuZy3gTcVs22ynZNrBZqWy5CjPw7KlouBUeVcnJ7R0PVqJBdbUpo7EKfoafAetAfTa5-_uryCGmqRMsXzhRP2rxmXNGIojWBrrSkeRYLuv1fMz0xN5-kSisNNH0De43pSIa1rN_Cjlvuw6u6mOT2HZxcuht0fZeOIOR6uyLrkow7OuYHR6rgX32OgZSenN5vrlckxGHJcDQeJe9hNp38Hp_TpjwCXQjB1lR6izNOGxabhTRC-szlwT3KjTTGqNgbnFsMXRatrU9V8FRswk2sjMpVinbJB-gty6U7AGJ9rLXJMs-EFV6YPLP4vky8WSjU72kEX1toituaBaPo-I4rHAvEsQg4FtsIjlvwimZCrIq_4ovgc_cYh3LITyA05aZqI9EEQ4sqgo816N3f0EsLZGcygm-tFP75-HNdOXy5K0fwmgX5V7tTjqG3vt-4T2hjrM0AdtN5itdsejaA_vDsz4_JoBlceHfGho-dPc9s
link.rule.ids 315,783,787,12070,12779,21402,27938,27939,31733,31734,33387,33388,33758,33759,41095,41537,42164,42606,43324,43614,43819,52125,52248,74081,74371,74638
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB5RUFUuCCiP8DQSp1YWSfxIckKwgLaF5QTS3iJ7bffUDbC7h-XXM3YegBCckzjW58d8M2N_A3CsOGPM2pwKYzjllhuq_WUfptLEFFJpFtT5B7eyf8__DsWwCbhNmmOV7Z4YNmpTjXyM_AQNLROcoUk5fXikvmqUz642JTS-wZLX4fLa-dmwc7iSLJO8VQtPJUvarGYcRESRS6AjLWiRx5zO39ulD2TzQ6I02J-rVVhpiCM5q0d6DRbseB2-16Uk5z_hdGD_o-M7tgQBV_MJmVak14kxP1sSQn_1LQZSOXLxNPs3IT4KS87Oe-fJBtxfXd71-rQpjkBHnKdTKpzB9aZ0GuuR0Fy43BbeOSq00FrL2GlcWSk6LEoZl0nvp5iE6VhqWcgMWckmLI6rsd0GYlyslM5zl3LDHddFbvB7kTg9kmjdswh-tdCUD7UGRtmpHQccS8Sx9DiW8wj2WvDKZjlMytfBi-Coe4wT2WcnEJpqFt4RSMCQT0WwVYPe_Q19NC91JiL43Y7Cm8Y_68rO1105hB_9u8FNefPn9noXllM_F8I5lT1YnD7N7D6yjak-CFPqBfpXzK0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTxsxEB7RVFS9IEqh3ZKCkXoCWeyuH7t7QhCIeIsDSLmt7Njm1GwgySH8-o69D6hQe96nPo893-cZzwD8UpwxZm1OhTGccssN1f6wD1NpYgqpNAvV-W9u5fkDvxyJUZP_NGvSKts1MSzUphr7PfJDdLRMcIYu5dA1aRF3p8Oj6RP1HaR8pLVpp_EBPmYcHR3adjbqxFeSZZK3lcNTyZI2whmHgqLIK1BUC1rkMafLv33UO-L5LmgafNFwHdYaEkmO61H_Ait2sgGrdVvJ5Vc4urG_UQRPLEHw1XJG5hUZdIWZXywJ24D1iQZSOXL6vHicEb8jS45PBifJJjwMz-4H57RplEDHnKdzKpzBuad0Guux0Fy43BZeKBVaaK1l7DTOshTFi1LGZdJrFpMwHUstC5khQ9mC3qSa2O9AjIuV0nnuUm6447rIDT4vEqfHEj19FsF-C005rethlF3l44BjiTiWHsdyGUG_Ba9spsasfB3ICPa6y2jUPlKB0FSLcI9AMobcKoJvNejd11Cv-bJnIoKDdhTevPxfv_Lj_7-yC5_Qmsrri9urbficelMIKSt96M2fF_YnEo-53gkW9QfB69Di
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Membrane+Assays+to+Characterize+Interaction+of+Drugs+with+ABCB1&rft.jtitle=The+Journal+of+membrane+biology&rft.au=Fekete%2C+Zsolt&rft.au=Rajnai%2C+Zsuzsanna&rft.au=Nagy%2C+T%C3%BCnde&rft.au=Jakab%2C+Katalin+Taubern%C3%A9&rft.date=2015-12-01&rft.eissn=1432-1424&rft.volume=248&rft.issue=6&rft.spage=967&rft.epage=977&rft_id=info:doi/10.1007%2Fs00232-015-9804-y&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2631&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2631&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2631&client=summon